baber/WOPTO huggingface dataset:
Patent CA-2624018-A1 (CA)
Inventor: KRANZLER JAY D
IPC: A61K31/165
Filed: 2006-09-27
Abstract: The present invention is directed to methods for providing long-term treatment of fibromyalgia syndrome (FMS) by administering a dual re-uptake inhibitor to a patient with FMS. More particularly, the present invention is directed to the long-term treatment of FMS by administering a norepinephrine-serotonin reuptake inhibitor (NSRI) to a patient with FMS.
Patent CA-2624200-A1 (CA)
Inventor: WILBANKS THOR MILLER
IPC: B23K26/067
Filed: 2006-10-02
Abstract: The invention provides a method of rapidly machining multiple, often similar or nearly identical, features using a LASER machining system. During LASER  machining, light of a wavelength and intensity that will modify the workpiece to be machined is directed at the workpiece and interacts to produce the desired change. If several features are to be machined, the processing speed can be increased by operating on a multiplicity of features at once. In one embodiment of the invention, this is achieved by separating the LASER beam into multiple beams and machining the desired features simultaneously.
Patent CA-2625664-A1 (CA)
Inventor: PARVEEN SOFIA
IPC: A61K39/395
Filed: 2006-10-19
Abstract: The present invention relates to human anti-IL-13 binding molecules, particularly antibodies, and to methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
Patent CA-2625940-A1 (CA)
Inventor: BERNATCHEZ-LEMAIRE IRMA
IPC: C07K7/08
Filed: 2006-08-23
Abstract: The invention relates to the use of Histogranin-like compounds to reduce P2X7( also designed P2Z) receptor function. The invention also provides a method for the prevention and treatment of rheumatoid arthritis and a variety of diseases/disorders including inflammatory disorders and neurodegenerative diseases.
Patent CA-2626144-A1 (CA)
Title: Ecaille a traitement superficiel
Inventor: RAKSHA VLADIMIR P
IPC: C09D7/80
Filed: 2008-03-18
Abstract: La présente invention concerne un flocon orientable asymétrique à utiliser dans une matière porteuse. Le flocon comprend une couche métallique réflectrice et un revêtement composé dun matériau repoussant la matière porteuse appliqué sur un seul côté du flocon, pour orienter ce dernier dans la matière porteuse afin que le flocon repose sur la matière porteuse en présentant un premier côté au moins partiellement hors de la matière porteuse et un deuxième côté immergé dans la matière porteuse. Le flocon comporte une caractéristique asymétrique, comme un revêtement à changement de couleur sur une seule surface de la couche réflectrice. Dans un autre mode de réalisation, la caractéristique asymétrique est soit un symbole en relief ou un profil asymétrique du flocon.
Patent CA-2627022-A1 (CA)
Title: Detection of intracellular enzyme complex
Inventor: FUNG PETER A
IPC: C12N15/87
Filed: 2006-10-24
Abstract: Methods and compositions are provided for determining intracellular translocation of proteins employing .beta.-galactosidase fragments that independently complex to form an active enzyme. Cells are used having two fusion constructs: one fragment bound to a protein of interest; and the other fragment bound to a compartment localizing signal. The cells are used to screen compounds for their effect on translocation, where a substrate containing high ionic strength solution is used for detection of the enzyme complex.
Patent CA-2628462-A1 (CA)
Inventor: MANNIUS ZU DEM BERGE JOHAN PAT
IPC: A61K9/70
Filed: 2006-10-30
Abstract: The present invention is directed towards a method for preparing and/or treating a fluid and/or moister absorbing basic material (1), illustrated as a textile soft material, to form an allergen or allergens impregnated material (2). It is here suggested a first processing step (S1), for the production of said absorbing basic material (a1 ), one or more intermediate processing steps (S2), for a sequential treatment of said basic absorbing material (1), including a first step (S2a) of adding one or more diluted antigen or antigens (5) to said dried absorbing basic material (1) in an extent to be fully absorbed by said material (1) and a second step (S2b) where said diluted antigen or antigens, within said absorbing basic material (1), and said material (1) is treated during an under-pressure sequence followed by an over-pressure sequence, or vice versa and, a final processing step (S3), where said treated absorbing material "a2", with diluted antigen or antigens (5), is dried (S3a) in order to form an allergen or allergens impregnated soft material (2).
Patent CA-2628515-A1 (CA)
Inventor: MRAZ PETER
IPC: D21B1/36
Filed: 2008-04-04
Abstract: A steam explosion pulping method including:  impregnating a cellulosic biomass feed material in a pressurized reactor vessel; discharging the impregnated feed material from the vessel to a high pressure compressor; elevating a pressure of the feed material in the compressor; discharging the pressurized feed material from the compressor to a conduit coupled to a blow valve;  rapidly reducing pressure of the pressurized feed material as the feed material passes through the blow valve, and pulping the feed material by expansion of fluid in the feed material during the rapid pressure reduction.
Patent CA-2628621-A1 (CA)
Title: Two-piece housing, reconfigurable with an integral hinge
Inventor: FRAWLEY LANNY J
IPC: H01R3/00
Filed: 2006-10-26
Abstract: An electrical unit has first and second attached housing sections. The sections are movable relative to one another and include internal conduits and conductors that extend between the sections.
Patent CA-2629037-A1 (CA)
Title: Compositions comprising a combination of ccr5 and cxcr4 antagonists
Inventor: BAROUDY BAHIGE M
IPC: A61P37/06
Filed: 2006-11-28
Abstract: A composition including a CXCR4 antagonist and a CCR5 antagonist represented by formula I or II: or an acceptable salt, solvate or ester thereof. The GXCR4 antagonist includes at least one of AMD-070. CS-3955, KRH-1 120, KRH-2731, and KRH-1636. These compositions are used to manufacture medicaments for the treatment of HIV infections.
Patent CA-2633372-A1 (CA)
Inventor: KIUCHI MASATOSHI
IPC: A61K47/22
Filed: 2006-12-14
Abstract: An object of the present invention is to provide an easily absorbable oral preparation containing a xanthine derivative or a pharmaceutically acceptable salt thereof and a fatty acid or a fatty acid derivative for the purpose of providing an easily absorbable oral preparation containing the xanthine derivative of which absorbability has been enhanced by dissolving the xanthine derivative that shows adenosine A1 receptor antagonistic activity and has diuretic activity, kidney-protecting activity, bronchodilating activity, cerebral function-improving activity, anti-dementia activity or the like in a solvent.
Patent CA-2633838-A1 (CA)
Inventor: ERICKSON JOHN P
IPC: C08G18/64
Filed: 2008-06-05
Abstract: An elastomeric composition includes a reaction product of an isocyanate component and a resin component comprising a polyol and a polyetheramine in the presence of a first catalyst comprising a metal and a second catalyst comprising an amine.  An elastomeric system and a method of making an elastomer are provided. The method includes providing the isocyanate component and the resin component, combining the resin component and the isocyanate component in the presence of the first and second catalysts to form an elastomeric composition, applying the elastomeric composition to a mold having a mold cavity, curing the elastomeric composition to form the elastomer, and demolding the elastomer from the mold cavity. An article including a first layer formed from the elastomeric composition emits less than 100 µg/g of volatile organic compounds over 0.5 hour at 90 °C.
Patent CA-2633958-A1 (CA)
Title: Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
Inventor: SNYDER DANIEL A
IPC: C07D211/60
Filed: 2006-12-15
Abstract: The present invention relates to heterocyclic compounds that bind to BcI  proteins and inhibit BcI function, compositions comprising such compounds, and methods for treating and modulating disorders associated with hyperproliferation, such as cancer.
Patent CA-2634306-A1 (CA)
Title: Drive mechanism and head rail for a blind
Inventor: WELFONDER KONRAD
IPC: E06B9/36
Filed: 2000-07-11
Abstract: A head rail for a vertical blind, the head rail being elongate and having a drive mechanism at one end for selectively tilting and retracting slats of the vertical blind along the length of the head rail, the drive mechanism including a rotatable tilt drive for tilting slats, a rotatable retract drive for retracting and deploying slats, and a transmission for rotating the tilt drive and the retract drive by means of a single rotatable source, wherein the transmission includes a clutch for rotating the tilt drive, the clutch incorporating a lost motion mechanism whereby, after a predetermined number of rotations in the same direction, transmission by the clutch to the tilt drive is disengaged and wherein the transmission includes a control gear which is located at a position along the length of the head rail so that it can be meshed with teeth of an external drive source.
Patent CA-2637236-A1 (CA)
Inventor: BERNAERT HERWIG
IPC: C07H17/06
Filed: 2007-01-15
Abstract: The present invention relates to a solvent-derived, cocoa extract comprising between 25 and 65% by weight of polyphenols, and uses thereof for improving a beer production process and the resulting beer product. The invention further relates to a method for improving a beer production process as well as the beer product resulting from it. The invention further relates to a beer product with improved quality such as enhanced colloidal, taste and flavor stability. The invention also provides a beer with exogenous polyphenols and a beer comprising at least one cocoa polyphenol. Furthermore, the present invention includes a use of exogenous polyphenols as process enhancer and a use of cocoa for enhancing filtration processes.
Patent CA-2637289-A1 (CA)
Title: Pi (.pi.) shaped cross-member
Inventor: FOWLER ARTHUR
IPC: B62D21/02
Filed: 2005-12-23
Abstract: A cross-member for supporting a vehicle chassis loads includes a generally shaped member including: i) a generally flat top sheet; ii) a first side sheet extending at an angle from the top sheet, along a length of the top sheet at a location inset from a first side edge of the top sheet such that the top sheet overhangs the first side sheet; iii) a second side sheet extending at an angle from the top sheet, along a length of the top sheet at a location inset from a second side edge of the top sheet such that the top sheet overhangs the second side sheet.
Patent CA-2637355-A1 (CA)
Title: Conformable heating pad
Inventor: YOUNGBLOOD JILL
IPC: A61F7/08
Filed: 2008-07-11
Abstract: A conforming heating pad having a curvilinear Y-shaped recess has a pair of opposed curved wing sections surrounding a centralized opening occupied by a central flap portion created by the Y-shaped recess. A pair of opposed multi-layer constructions housing a resistive NTC sensing wire and a plurality of individual weights serve to enhance the conformity of the heating pad. The heating pad is operable in at least two modes, including a constant heating level mode at various user-selectable temperature levels and a timed mode that offers user-selectable temperature levels over a user--selectable period of time. The heating pad can be wetted to offer a moist heat therapy.
Patent CA-2638745-A1 (CA)
Inventor: YAZID SAIDI M
IPC: C01G31/00
Filed: 2001-11-19
Abstract: Méthode permettant de fabriquer un composé de lithium et d'un oxyde de métal de transition destiné à être utilisé comme matière active de cathode. Cette méthode comprend le mélange des produits de départ sous forme particulaire, soit au moins un composé du lithium, au moins un oxyde de métal de transition, et au moins un réducteur sous forme particulaire, puis le chauffage de ce mélange de produits de départ jusqu'à l'atteinte d'une température suffisante pour former un composé de lithium et d'oxyde de métal de transition.
Patent CA-2641019-A1 (CA)
Title: Access port using shape altering anchor
Inventor: SUNG JASON
IPC: A61L31/02
Filed: 2008-10-14
Abstract: The present disclosure provides access ports for use in surgery. The access ports possess a distal end which adopts an alternate shape upon the application of energy, thereby securing the access port to tissue. Alternatively, the access port may have barbs on a surface thereof which are formed upon the application of energy, thereby securing the access port to tissue.
Patent CA-2643329-A1 (CA)
Title: Abstract execution model for a continuation-based meta-runtime
Inventor: SCHMIDT ROBERT B
IPC: G06Q99/00
Filed: 2007-02-21
Abstract: Providing a workflow engine for virtualizing a managed execution environment. The workflow engine executes a workflow based on an automaton and methods associated therewith. The workflow engine captures continuations associated with the executing workflow to enable modeling of real-world processes.
Patent CA-2643729-A1 (CA)
Title: Devices, systems, and methods for providing electrical power
Inventor: HOOPER WILLIAM P
IPC: H02H5/10
Filed: 2007-02-13
Abstract: Certain exemplary embodiments comprise an electrical power distribution panel, which can comprise a Source Line Evaluation Detector. The Source Line Evaluation Detector can be configured to open a contactor responsive to at least one condition from a plurality of monitored electrical source line conditions. The Source Line Evaluation Detector can be configured to monitor the one or more monitored electrical source line conditions.
Patent CA-2647181-A1 (CA)
Title: Antibodies against insulin-like growth factor i receptor and uses thereof
Inventor: SCHUMACHER RALF
IPC: C07K16/28
Filed: 2007-04-10
Abstract: An antibody binding to IGF-IR, being of human IgG1 or IgG3 type and being glycosylated with a sugar chain at Asn297, said antibody being characterized in that the amount of fucose within said sugar chain is at least 99%, and in addition the amount of NGNA is 1% or less and/ or the amount of N-terminal alpha-1,3- galactose is 1% or less has improved properties in antitumor therapy.
Patent CA-2647294-A1 (CA)
Title: Fluid powered dual-piston actuator with efficient fluid porting and method of implementation
Inventor: BAYREUTHER DAVID
IPC: F16N11/10
Filed: 2007-01-31
Abstract: In an actuator, a first piston is attached to a first toothed rack, and a second piston is attached to a second toothed rack. A rotary member is attached to one pinion mating with the first or second toothed racks. A first volume is disposed in the cavity on one side of the first piston. A second volume is disposed in the cavity on another side of the first piston. A third volume is disposed on a side of the second piston opposite the second volume. A first fluid port is in fluid communication with the first volume via a primary fluid passage. A second fluid port, which is external to the cavity, is in fluid communication with the second volume. A fluid passage in the housing, external to the cavity and separate from the primary fluid passage connects the first and third volumes independently of the primary fluid passage..
Patent CA-2649498-A1 (CA)
Inventor: SEREBRIANSKI VALERI VASILIEVICH
IPC: E21B47/10
Filed: 2006-12-22
Abstract: The invention relates to the geophysical examination of wells and can be used for determining the electrical resistivity of rock beds surrounding a well cased in a metal column. The inventive method consists in using a sonde embodied in the form of two current electrodes located on the opposite sides with respect of at least thee measuring electrodes, in alternately supplying electric current, in measuring, by means of a measuring devices, during each current supply, a supplied current, a potential on a central measuring electrode and the potential difference between the outer measuring electrodes and the central electrode, in using the specific electrical resistivity of the rock beds surrounding the cased well in the form of the electrical parameter of the electrical logging of the cased wells, in forming a measuring circuit according to the resistivity pattern of the layers of the rock beds surrounding the well and of those sections of a casing string which are provided with the collars, wherein the sonde, whose measuring electrodes are spaced without respecting equidistance requirements and current electrodes are embodied in such a way that they can be used in the form of measuring electrodes is applied. In addition, the inventive method also consists in measuring the potential difference of an electric field between the current electrode, to which the current is not supplied at the present switching, and the central measuring electrode, by means of additional measuring devices, and in determining a specific electrical resistivity according to a formula referred thereto.
Patent CA-2649953-A1 (CA)
Title: Fuel cell assembly using multiple fuel cell stacks and control method therefor
Inventor: BERNTSEN GEORGE
IPC: H01M8/04
Filed: 2007-05-02
Abstract: A multi-stack assembly receiving fuel from a fuel supply and producing power output for consumption by a load, the assembly comprising a plurality of fuel cell stacks for producing DC power and forming a plurality of fuel cell stack groups, wherein each of the stack groups includes at least one fuel cell stack, a plurality of inverters corresponding to the plurality of fuel cell stack groups, wherein each of the inverters draws a predetermined amount of DC power from a corresponding fuel cell stack group and converts the DC power to AC power; and a controller for controlling each of the inverters to draw the predetermined amount of DC power from the corresponding fuel cell stack group so as to satisfy power requirements of the load.
Patent CA-2652322-A1 (CA)
Title: Organ-adhesion preventing agent and process for preventing adhesion using thereof
Inventor: SHICHINOHE MAKOTO
IPC: A61K31/785
Filed: 2007-05-11
Abstract: An agent for preventing organ adhesion containing a .gamma.-polyglutamic acid chemically crosslinked substance as an active ingredient and a method f or preventing organ adhesion characterized by contacting or adhering the age nt for preventing organ adhesion to the local surface of, or as the case may be, around an organ whose postoperative adhesion is desired to prevent are disclosed. According to the invention, the adhesion of the surface of the or gan can be prevented effectively and the agent for preventing organ adhesion which is absorbed in the body, is highly safe, can be easily produced, and is highly practical, and the method for preventing organ adhesion using the same are provided.
Patent CA-2652643-A1 (CA)
Inventor: MC CLINTOCK JASON T
IPC: B63C9/08
Filed: 2007-05-01
Abstract: A life vest (20) having a built-in two-way radio (30). The two-way radio (30) may be mounted behind a protective covering (44). The protective covering (44) includes contours that match buttons (36, 38) for the two-way radio (30), and depressing or otherwise actuating the contours results in actuation of the corresponding buttons or controls (36, 38) for the two-way radio (30). A life vest (220) may have an MP3 player (230) in a pocket (242) of the life vest (220) and may be behind a protective covering (244).
Patent CA-2653385-A1 (CA)
Inventor: KIDD SCOTT D
IPC: G06F19/00
Filed: 2007-06-05
Abstract: In one embodiment, the present invention includes a computer-implemented method to collect information to determine damage to a vehicle involved in a collision using photogrammetric techniques. When determined, this vehicle damage information, which may be in the form of crush measurement information such as a crush damage profile, can be displayed in a computer-generated view of the subject vehicle with a crush damage profile and used to estimate the impact severity. In some embodiments, based on the photogrammetric information derived, a direction of any shifting of the vehicle's components may be obtained and used along with other information to estimate a principal direction of force (PDOF) for one or more vehicles involved in the collision. Still further embodiments may be used to generate and/or audit repair estimates based at least in part on the photogrammetric information.
Patent CA-2656017-A1 (CA)
Inventor: ZHOU TIELING
IPC: A61K31/4418
Filed: 2006-09-25
Abstract: L'invention concerne l'utilisation de composés possédant une structure de pyridones pour le traitement par radioactivité d'une lésion des poumons. Les expériences montrent que des composés possédant une structure de pyridones peuvent prévenir par radioactivité une lésion des poumons causée par la radiothérapie et l'augmentation de dose de rayonnement auprès de patients pendant la radiothérapie.
Patent CA-2656068-A1 (CA)
Inventor: RICHTER HANS-PETER
IPC: G01N21/3563
Filed: 2007-06-08
Abstract: The invention relates to a method for analyzing a layer of a metal working compound (50) on the surface of a product to be shaped (40), especially of a metal strip, before and/or after a shaping process, especially a rolling process, for various measuring variables. According to the invention, analysis of the metal working compound (50) is carried out by way of spectroscopic analysis. The invention also relates to a method for carrying out the method according to the invention.
Patent CA-2656558-A1 (CA)
Inventor: GRIFFITH WILLIAM
IPC: C07K14/755
Filed: 2007-06-29
Abstract: Provided herein are methods and compositions for producing Factor VIII proteins. Such methods include introducing into a cell a nucleic acid molecule encoding a Factor VIII protein operably linked to a promoter, wherein the promoter is characterized by the ability to produce commercially viable Factor VIII protein; and incubating the cell under conditions for producing commercially viable Factor VIII protein. Also provided are nucleic acid molecules which encode a Factor VIII protein operably linked to a Chinese hamster elongation factor 1-.alpha. (CHEF1) promoter, which may be used in the methods provided herein.
Patent CA-2659275-A1 (CA)
Title: Chimeric influenza virus-like particles
Inventor: HAYNES JOEL R
IPC: A61P37/04
Filed: 2007-07-27
Abstract: Chimeric Influenza virus-like particles including gag polypeptides are described. Virus-like particles are generated with a gag polypeptide, a neuraminidase polypeptide and optionally a hemagglutinin polypeptide. Preferred methods of generation include expression in insect cells.
Patent CA-2660152-A1 (CA)
Inventor: EMERSON TOD D
IPC: H01R4/60
Filed: 2007-07-28
Abstract: A connector for electrically and mechanically connecting insulated conductor wires (170a, 170b) encapsulate in protective tubing. Embodiments of the connector provide a protective outer sheathing (450) that circumscribe the conductive and insulating structures within the connector. The connector is formed with a plurality of tubular fitting assemblies (233a, 233b, 233c) for securely attaching the connector to down hole electrical power cables (170). The connector is also formed with an internal insulating boot (470) having an internal passage adapted to surround the conductive elements of the connector to provide a reliable down hole electrical connector.
Patent CA-2660590-A1 (CA)
Title: A method and apparatus for fast other sector interference (osi) adjustment
Inventor: BORRAN MOHAMMAD J
IPC: H04W72/08
Filed: 2007-09-05
Abstract: Systems and methods that facilitate management of interference and communication resources are provided. A differential approach is devised in which other-sector interference (OSI) and communication resources are managed by adjusting an offset (delta) value associated with the resources in response to receiving an indication of other-sector interference. An OSI indication can be issued based on a short and a long time scale, and effective interference metrics over time-frequency resources. The adjusted delta value is communicated to a serving access point, which reassigns communication resources in order to mitigate other-sector interference.